| TGFB1 |
TGFB1, TGFB: Transforming growth factor beta-1 precursor |
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
0.795 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
VTN |
VTN: Vitronectin precursor |
0.795 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
HPX |
HPX: Hemopexin precursor |
0.795 |
Evidence |
|
| SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
VTN |
VTN: Vitronectin precursor |
0.795 |
Evidence |
|
| SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
HPX |
HPX: Hemopexin precursor |
0.795 |
Evidence |
|
| CFB |
CFB, BF, BFD: Complement factor B precursor |
ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
0.795 |
Evidence |
|
| CFB |
CFB, BF, BFD: Complement factor B precursor |
IGFALS |
IGFALS, ALS: Insulin-like growth factor-binding protein complex acid labile chai |
0.795 |
Evidence |
|
| F12 |
F12: Coagulation factor XII precursor |
APOA2 |
APOA2: Apolipoprotein A-II precursor |
0.795 |
Evidence |
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
GNB2L1 |
Lung cancer oncogene 7 |
0.795 |
Evidence |
|
| KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
RBM14 |
RBM14, SIP: RNA-binding protein 14 |
0.795 |
Evidence |
|
| KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
DDX46 |
DDX46, KIAA0801: Probable ATP-dependent RNA helicase DDX46 |
0.795 |
Evidence |
|
| KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
CHD4 |
CHD4: Chromodomain-helicase-DNA-binding protein 4 |
0.795 |
Evidence |
|
| KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
0.795 |
Evidence |
|
| SF3B1 |
SF3B1, SAP155: Splicing factor 3B subunit 1 |
ELF1 |
ELF1: ETS-related transcription factor Elf-1 |
0.795 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
0.795 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
0.795 |
Evidence |
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
DDX46 |
DDX46, KIAA0801: Probable ATP-dependent RNA helicase DDX46 |
0.795 |
Evidence |
|
| SMARCA5 |
SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul |
DDX46 |
DDX46, KIAA0801: Probable ATP-dependent RNA helicase DDX46 |
0.795 |
Evidence |
|
| SMARCA5 |
SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul |
RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
0.795 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
STK10 |
STK10: Uncharacterized protein STK10 |
0.795 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
GMIP |
GMIP: GEM-interacting protein |
0.795 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
STK38 |
STK38, NDR1: Serine/threonine-protein kinase 38 |
0.795 |
Evidence |
|
| FOXO3A |
FOXO3A, FKHRL1: Forkhead box protein O3A |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
0.795 |
Evidence |
|
| TNFSF12 |
TNFSF12, APO3L, UNQ181/PRO207, DR3LG: Tumor necrosis factor ligand superfamily m |
CD14 |
CD14: Monocyte differentiation antigen CD14 precursor |
0.795 |
Evidence |
|
| TNFSF12 |
TNFSF12, APO3L, UNQ181/PRO207, DR3LG: Tumor necrosis factor ligand superfamily m |
TLR2 |
TLR2, TIL4: Toll-like receptor 2 precursor |
0.795 |
Evidence |
|